Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Analysts Offer Insights on Healthcare Companies: Ovid Therapeutics (OVID) and Corbus Pharmaceuticals (CRBP)
10:38am, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ovid Therapeutics (OVID) and Corbus Pharmaceuticals (CRBP)
Analysts Offer Insights on Healthcare Companies: Ovid Therapeutics (NASDAQ: OVID) and Corbus Pharmaceuticals (NASDAQ: CRBP)
10:38am, Friday, 13'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ovid Therapeutics
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Down 9.5%
08:00am, Friday, 13'th Mar 2020
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) traded down 9.5% on Wednesday . The stock traded as low as $3.98 and last traded at $4.12, 1,143,323 shares changed hands during trading. An increase
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript
08:00pm, Thursday, 12'th Mar 2020
CRBP earnings call for the period ending December 31, 2019.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q4 2019 Results - Earnings Call Transcript
04:43pm, Thursday, 12'th Mar 2020
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Q4 2019 Earnings Conference Call March 12, 2020 8:30 AM ET Company Participants Ted Jenkins - Senior Directo
Corbus Pharmaceuticals (CRBP) Reports Q4 Loss, Lags Revenue Estimates
12:55pm, Thursday, 12'th Mar 2020
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of -20.59% and -44.55%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the s
Corbus Pharmaceuticals (CRBP) Reports Q4 Loss, Lags Revenue Estimates
12:55pm, Thursday, 12'th Mar 2020
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of -20.59% and -44.55%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the s
Corbus Pharmaceuticals: 4Q Earnings Snapshot
11:59am, Thursday, 12'th Mar 2020
NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc. (CRBP) on Thursday reported a loss of $26.6 million in its fourth quarter. The Norwood, Massachusetts-based company said it had a loss of 41
Corbus Pharmaceuticals: 4Q Earnings Snapshot
11:58am, Thursday, 12'th Mar 2020
NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc. (CRBP) on Thursday reported a loss of $26.6 million in its fourth quarter.
The Norwood, Massachusetts-based company said it had a loss of 41
Corbus expects cash, cash equivalents to fund operations into 4Q20 CRBP
11:36am, Thursday, 12'th Mar 2020
Corbus expects cash, cash equivalents to fund operations into 4Q20 CRBP
Corbus expects safety data from Phase 1 study of CRB-4001 in 2020 CRBP
11:34am, Thursday, 12'th Mar 2020
Corbus expects safety data from Phase 1 study of CRB-4001 in 2020 CRBP
Corbus Pharmaceuticals reports Q4 EPS (41c), consensus (36c) CRBP
11:34am, Thursday, 12'th Mar 2020
Corbus Pharmaceuticals reports Q4 EPS (41c), consensus (36c) CRBP
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results
11:05am, Thursday, 12'th Mar 2020
Topline results for Phase 3 study in systemic sclerosis on schedule for summer of 2020 followed by Phase 2b study results in cystic fibrosis Completed $46 million public.
Corbus Pharmaceuticals Holdings, Inc. to Host Earnings Call
10:30am, Thursday, 12'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 12, 2020 / Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on Marc
